BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 29241150)

  • 1. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
    Xu L; Oštrbenk A; Poljak M; Arbyn M
    J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VALGENT: A protocol for clinical validation of human papillomavirus assays.
    Arbyn M; Depuydt C; Benoy I; Bogers J; Cuschieri K; Schmitt M; Pawlita M; Geraets D; Heard I; Gheit T; Tommasino M; Poljak M; Bonde J; Quint W
    J Clin Virol; 2016 Mar; 76 Suppl 1():S14-S21. PubMed ID: 26522865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening.
    Arbyn M; Simon M; Peeters E; Xu L; Meijer CJLM; Berkhof J; Cuschieri K; Bonde J; Ostrbenk Vanlencak A; Zhao FH; Rezhake R; Gultekin M; Dillner J; de Sanjosé S; Canfell K; Hillemanns P; Almonte M; Wentzensen N; Poljak M
    Clin Microbiol Infect; 2021 Aug; 27(8):1083-1095. PubMed ID: 33975008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
    Oštrbenk Valenčak A; Cuschieri K; Connor L; Zore A; Smrkolj Š; Poljak M
    J Clin Virol; 2024 Feb; 170():105638. PubMed ID: 38183829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AmpFire HPV and ScreenFire RS HPV validation trial.
    Hou J; Belinson JL; Du H; Li C; Zhang W; Zhang L; Zhang Y; Qu X; Wu R
    Am J Clin Pathol; 2024 Jun; 161(6):535-542. PubMed ID: 38365314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
    Castle PE; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Wacholder S; Burk RD; Manos MM; Schussler JE; Macomber P; Schiffman M
    J Clin Microbiol; 2003 Sep; 41(9):4022-30. PubMed ID: 12958220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.
    Wagner S; Roberson D; Boland J; Yeager M; Cullen M; Mirabello L; Dunn ST; Walker J; Zuna R; Schiffman M; Wentzensen N
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30814267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay.
    Chung PYJ; Dhillon SK; Baraquin A; Tkachenka Y; Jacquot K; Prétet JL; Broeck DV; Arbyn M
    J Med Virol; 2024 Jun; 96(6):e29688. PubMed ID: 38847316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of HPV genotyping: A study on the performance concordance between Anyplex II HPV28 detection and Linear Array genotyping tests in nationwide studies in Brazil.
    Bandeira IC; Comerlato J; Bessel M; Fernandes BV; Mota G; Villa LL; de Souza FMA; Pereira GFM; Wendland EM
    PLoS One; 2024; 19(6):e0305122. PubMed ID: 38861542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
    Pasquier C; Raymond S; Carcenac R; Demmou S; Ranger N; Nicot F; Izopet J
    J Med Virol; 2024 May; 96(5):e29652. PubMed ID: 38727029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes.
    Wagner S; Roberson D; Boland J; Kreimer AR; Yeager M; Cullen M; Mirabello L; Dunn ST; Walker J; Zuna R; Porras C; Cortes B; Sampson J; Herrero R; Rodriguez AC; Quint W; Van Doorn LJ; ; Hildesheim A; Schiffman M; Wentzensen N
    J Infect Dis; 2019 Oct; 220(10):1609-1619. PubMed ID: 31536132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.
    Cuschieri KS; Cubie HA; Whitley MW; Seagar AL; Arends MJ; Moore C; Gilkisson G; McGoogan E
    J Clin Pathol; 2004 Jan; 57(1):68-72. PubMed ID: 14693839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania.
    Ursu RG; Onofriescu M; Nemescu D; Iancu LS
    Virol J; 2011 Dec; 8():558. PubMed ID: 22192090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of Anyplex II HPV28 and Allplex HPV28 molecular assays for human papillomavirus detection and genotyping in anogenital cancer screening.
    Naegele K; Bubendorf L; Hirsch HH; Leuzinger K
    J Med Virol; 2024 Jun; 96(6):e29649. PubMed ID: 38812416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria.
    Kennedy NT; Ikechukwu D; Goddy B
    Pan Afr Med J; 2016; 23():85. PubMed ID: 27222684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China.
    Zhang L; Xu XQ; Hu SY; Chen F; Zhang X; Pan QJ; Zhang WH; Feng RM; Dong L; Zhang Q; Ma JF; Sauvaget C; Zhao FH; Qiao YL; Sankaranarayanan R
    Gynecol Oncol; 2018 Nov; 151(2):221-228. PubMed ID: 30269870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of operational factors on HPV positivity rates in an HPV-based screening study in Colombia.
    Robles C; Wiesner C; Martinez S; Salgado Y; Hernandez M; Lucas E; Lineros J; Romero P; Herrero R; Almonte M; Murillo R
    Int J Gynaecol Obstet; 2018 Oct; 143(1):44-51. PubMed ID: 29944728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools.
    Kulmala SM; Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Podistov J; Ivanchenko O; Zakharenko S; Nerovjna R; Kljukina L; Branovskaja M; Grunberga V; Juschenko A; Tosi P; Santopietro R; Syrjänen K
    J Clin Microbiol; 2004 Jun; 42(6):2470-5. PubMed ID: 15184422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring.
    Kang Z; Stevanović S; Hinrichs CS; Cao L
    Clin Cancer Res; 2017 Nov; 23(22):6856-6862. PubMed ID: 28899967
    [No Abstract]   [Full Text] [Related]  

  • 20. HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions.
    Ilisiu MB; Hashim D; Andreassen T; Støer NC; Nicula F; Weiderpass E
    Ann Glob Health; 2019 Jun; 85(1):. PubMed ID: 31225959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.